Screener
OraSure Technologies OSUR Q2 2026 earnings
Reported August 5, 2026 · After market close
Revenue$30.6MBeat by $1.5M
EPS$0.09Beat by $0.36
Revenue estimate$29.1M
EPS estimate-$0.27
“Our Q2 results demonstrate continued progress in our return-to-growth trajectory, with revenue of $30.6 million, up 9.7% sequentially and above our guidance range, along with solid gross margin improvement. We also advanced key innovation milestones, including recent FDA clearance of our Colli-Pee™•Dx at-home urine collection device for sexually transmitted infections, and FDA Emergency Use Authorization of our OraQuick™ Ebola 2.0 Rapid Antigen Test.”
Next report
Nov 4, 2026 (in a month)Revenue estimate$31.1M
EPS estimate-$0.23
Segments
Versus estimates
Revenue
Diluted EPS
FAQ
- When did OraSure Technologies report Q2 2026 earnings?
- OraSure Technologies (OSUR) reported Q2 2026 earnings on August 5, 2026 after market close.
- What were OraSure Technologies's Q2 2026 revenue and EPS?
- OraSure Technologies reported revenue of $30.6M and eps of $0.09 for Q2 2026.
- Did OraSure Technologies beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $29.1M by $1.5M. EPS beat the consensus estimate of $-0.27 by $0.36.
- How did OraSure Technologies's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 97969.9% from $31.2K a year earlier.
- Where can I find OraSure Technologies's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001116463-26-000048) and the 10-Q periodic report (0001116463-26-000052) directly on SEC EDGAR. The filing index links above go to sec.gov.
